Wei Ling 魏玲

Researcher Number	80783638
Other IDs	https://orcid.org/0000-0001-6633-6410
Affiliation (based on the past Project Information) *help	2016: 大阪大学, 医学系研究科, 特任助教(常勤)
Review Section/Research Field	Principal Investigator General pharmacology
Keywords	Principal Investigator ハロゲン化芳香族アミノ酸誘導体 / 構造活性相関 / トランスポーター / α線内用療法 / 癌

Development of a halogenated derivative of aromatic amino acids for the targeted alpha-radionuclide therapy with high tumor specificity and low renal background.Principal Investigator
- Principal Investigator
  
  Wei Ling
- Project Period (FY)
  2016
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  General pharmacology
- Research Institution
  Osaka University

All 2017 2016

All Journal Article Presentation

[Journal Article] Expression of a human NPT1/SLC17A1 missense variant which increases urate export.2016
- Author(s)
  Sakiyama M, Matsuo H, Nagamori S, Wei L, Kawamura Y, Nakayama A, Higashino T, Chiba T, Ichida K, Kanai Y, Shinomiya N.
- Journal Title
  
  Nucleosides Nucleotides Nucleic Acids.
  
  Volume: 35 Pages: 536-542
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16H06942
[Journal Article] Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition kinetics, sidedness of action, and transporter-associated incorporation accounting for its pharmacodynamic and pharmacokinetic features.2016
- Author(s)
  Ohgaki R, Wei L, Yamada K, Hara T, Kuriyama C, Okuda S, Ueta K, Shiotani M, Nagamori S, Kanai Y.
- Journal Title
  
  J Pharmacol Exp Ther.
  
  Volume: 358 Issue: 1 Pages: 94-102
- DOI
  10.1124/jpet.116.232025
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04685, KAKENHI-PROJECT-16H06942, KAKENHI-PROJECT-15K15053, KAKENHI-PROJECT-15K08273, KAKENHI-PROJECT-15K08274
[Presentation] SGLT2阻害薬カナグリフロジンのヒトSGLT1およびSGLT2に対する作用キネティクスと阻害メカニズムの検討2017
- Author(s)
  大垣隆一、Ling Wei、山田和徳、原大樹、栗山千亜紀、奥田傑、植田喜一郎、Laurent Leclercq、Rao N.V.S. Mamidi、塩谷正治、永森收志、金井好克
- Organizer
  第90回日本薬理学会年会
- Place of Presentation
  長崎
- Year and Date
  2017-03-15
- Data Source
  KAKENHI-PROJECT-16H06942
[Presentation] 有機アニオントランスポーターOAT1に対する芳香族アミノ酸誘導体の構造活性相関：イメージングプローブの腎臓におけるバックグラウンド集積を誘起する分子内構造の同定2017
- Author(s)
  魏玲、大垣隆一、富永英之、兼田加珠子、奥田傑、永森收志、金井好克
- Organizer
  第90回日本薬理学会年会
- Place of Presentation
  長崎
- Year and Date
  2017-03-15
- Data Source
  KAKENHI-PROJECT-16H06942

1. NAGAMORI Shushi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. OHGAKI Ryuichi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 奥田傑

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. 金井好克

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Wei Ling 魏玲

Research Projects

Research Products

Co-Researchers

Development of a halogenated derivative of aromatic amino acids for the targeted alpha-radionuclide therapy with high tumor specificity and low renal background.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Expression of a human NPT1/SLC17A1 missense variant which increases urate export.2016

Author(s)

Journal Title

Data Source

[Journal Article] Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition kinetics, sidedness of action, and transporter-associated incorporation accounting for its pharmacodynamic and pharmacokinetic features.2016

Author(s)

Journal Title

DOI

Data Source

[Presentation] SGLT2阻害薬カナグリフロジンのヒトSGLT1およびSGLT2に対する作用キネティクスと阻害メカニズムの検討2017

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 有機アニオントランスポーターOAT1に対する芳香族アミノ酸誘導体の構造活性相関：イメージングプローブの腎臓におけるバックグラウンド集積を誘起する分子内構造の同定2017

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

Wei Ling 魏 玲

Research Projects

Research Products

Co-Researchers

Development of a halogenated derivative of aromatic amino acids for the targeted alpha-radionuclide therapy with high tumor specificity and low renal background.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Expression of a human NPT1/SLC17A1 missense variant which increases urate export.2016

Author(s)

Journal Title

Data Source

[Journal Article] Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition kinetics, sidedness of action, and transporter-associated incorporation accounting for its pharmacodynamic and pharmacokinetic features.2016

Author(s)

Journal Title

DOI

Data Source

[Presentation] SGLT2阻害薬カナグリフロジンのヒトSGLT1およびSGLT2に対する作用キネティクスと阻害メ カニズムの検討2017

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 有機アニオントランスポーターOAT1に対する芳香族アミノ酸誘導体の構造活性相関：イ メージングプローブの腎臓におけるバックグラウンド集積を誘起する分子内構造の同定2017

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

Wei Ling 魏玲

[Presentation] SGLT2阻害薬カナグリフロジンのヒトSGLT1およびSGLT2に対する作用キネティクスと阻害メカニズムの検討2017

[Presentation] 有機アニオントランスポーターOAT1に対する芳香族アミノ酸誘導体の構造活性相関：イメージングプローブの腎臓におけるバックグラウンド集積を誘起する分子内構造の同定2017